Groundbreaking Marburg Vaccine Trial Launches in Rwanda, Pioneering Global Efforts
In a groundbreaking development, the World Health Organization (WHO) has officially reported that Rwanda is spearheading the world's inaugural clinical trial aimed at treating the Marburg virus disease.
Dr. Matshidiso Moeti, the WHO Regional Director for Africa, emphasized the collaborative effort with the organization, which involves testing a medication currently employed for COVID-19 management—Remdesivir—alongside an antibody specifically engineered to combat the Marburg virus. “This initiative showcases our collective…